CDT
NASD CDT Equity Inc.$0.9900 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9900, $0.2900 below the day’s high of $1.2800
- YTD change
- -96.91%
- vs 20-day SMA
- -84.29%
- vs 200-day SMA
- -97.57%
Price ranges
Price & Performance
-2.96 (-74.94%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $483,375.0000
- CDT is down 97% since the beginning of the year
- CDT is down 94% over the past 12 months
- CDT is down 96% over the past 1 month
- 21% of all CDT investors are betting against CDT
CDT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +46.6%.
- Previous minute
- -$0.0100
- Last hour
- -$0.0599
- Last 5 days
- -67.27%
- vs 8-day SMA
- -55.79%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.